Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Reward Function and Therapy for Late-Life Depression: Complete Statistical AnalysisIndependent statistical analysis of Reward Function and Therapy for Late-Life Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03688139).
- Reward Processes and Rehearsal in Exposure Therapy: Complete Statistical AnalysisIndependent statistical analysis of Reward Processes and Rehearsal in Exposure Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06132425).
- Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic: Complete Statistical AnalysisIndependent statistical analysis of Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RHA® 4 NLF Cannula: Complete Statistical AnalysisIndependent statistical analysis of RHA® 4 NLF Cannula: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04754646).
- RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows: Complete Statistical AnalysisIndependent statistical analysis of RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04577898).
- RHA® Redensity With New Anesthetic Agent – Perioral Rhytids: Complete Statistical AnalysisIndependent statistical analysis of RHA® Redensity With New Anesthetic Agent - Perioral Rhytids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04069585).
- RHAPSODYIndependent statistical analysis of Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rheos® Pivotal Trial: Complete Statistical AnalysisIndependent statistical analysis of Rheos® Pivotal Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442286).
- RHINEIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RHINTRACIndependent statistical analysis of RhinAer Procedure for Treatment of Chronic Rhinitis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04533438).
- Rhodiola Rosea Therapy of Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Rhodiola Rosea Therapy of Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01098318).
- Rhythm-based Intervention in Aphasia: Complete Statistical AnalysisIndependent statistical analysis of Rhythm-based Intervention in Aphasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04581564).
- Ri-CoDIFy 1Independent statistical analysis of Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03595553).
- Ri-CoDIFy 3Independent statistical analysis of Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04802837).
- RI-US XLIndependent statistical analysis of Resolute Integrity US Extended Length Sub-Study(RI US XL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01913600).
- RIAIndependent statistical analysis of Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RibFxIndependent statistical analysis of Orthosis of Acute Traumatic Rib Fractures Via RibFx Belt for Pain Alleviation and Improved Pulmonary Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy – A Randomized, Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RICHIndependent statistical analysis of Repair of Infected or Contaminated Hernias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00617357).
- Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03176472).
- Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ridge Preservation After Tooth Extraction Using Cortical Versus Cancellous Freeze Dried Bone Allograft: Complete Statistical AnalysisIndependent statistical analysis of Ridge Preservation After Tooth Extraction Using Cortical Versus Cancellous Freeze Dried Bone Allograft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RIDILOTT-DVTIndependent statistical analysis of Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03413618).
- Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease: Complete Statistical AnalysisIndependent statistical analysis of Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Rifaximin Therapy in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Rifaximin Therapy in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02342639).
- RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope: Complete Statistical AnalysisIndependent statistical analysis of RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01965938).
- RIGHT ChoiceIndependent statistical analysis of the randomized phase 2 RIGHT Choice trial of ribociclib plus goserelin acetate with hormonal therapy versus combination chemotherapy in premenopausal or perimenopausal patients with advanced or metastatic breast…
- RIGHT: Rhythm ID Going Head-to-Head Trial: Complete Statistical AnalysisIndependent statistical analysis of RIGHT: Rhythm ID Going Head-to-Head Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00148954).
- RILECSUIndependent statistical analysis of Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine: primary endpoint results, effect estimate with confidence interval, sample-size…
- RiLEYIndependent statistical analysis of 9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00523718).
- Riluzole in the Treatment of Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Riluzole in the Treatment of Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00544544).
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders: Complete Statistical AnalysisIndependent statistical analysis of Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RIM4DMDIndependent statistical analysis of Rimeporide in Patients With Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02710591).
- RIPCOM1Independent statistical analysis of The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RISEIndependent statistical analysis of Raising Insulin Sensitivity in Post Menopause: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02274571).
- RISEIndependent statistical analysis of Research Intervention to Support Healthy Eating and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04353258).
- RISEIndependent statistical analysis of Rural Interventions for Screening Effectiveness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02795104).
- RISEIndependent statistical analysis of Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RISE AdultIndependent statistical analysis of RISE Adult Medication Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01779362).
- RISE-IIPComplete statistical analysis of RISE-IIP, the randomized phase 2 trial of riociguat versus placebo in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias.
- RISE-MIndependent statistical analysis of Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03634800).
- RISE-UPIndependent statistical analysis of Risk Information and Skin-cancer Education for Undergraduate Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03979872).
- RISE+Independent statistical analysis of Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Risk Identification of the GlucoTab System in Routine Use: Complete Statistical AnalysisIndependent statistical analysis of Risk Identification of the GlucoTab System in Routine Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02053077).
- Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins: Complete Statistical AnalysisIndependent statistical analysis of Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma: Complete Statistical AnalysisIndependent statistical analysis of Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…